Mariangela Figini

3.7k total citations · 1 hit paper
66 papers, 2.6k citations indexed

About

Mariangela Figini is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Mariangela Figini has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Mariangela Figini's work include Monoclonal and Polyclonal Antibodies Research (33 papers), CAR-T cell therapy research (14 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Mariangela Figini is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (33 papers), CAR-T cell therapy research (14 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Mariangela Figini collaborates with scholars based in Italy, United States and United Kingdom. Mariangela Figini's co-authors include Silvana Canevari, Mathilde Poussin, Daniel J. Powell, Qunrui Ye, Delia Mezzanzanica, Elena Luison, Marina Bagnoli, James Spicer, Sophia N. Karagiannis and Anthony Cheung and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mariangela Figini

65 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting folate receptor alpha for cancer treatment

2016 348 citations Anthony Cheung, Heather J. Bax et al. profile →

Peers

Countries citing papers authored by Mariangela Figini

Since Specialization

Citations

This map shows the geographic impact of Mariangela Figini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariangela Figini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariangela Figini more than expected).

Fields of papers citing papers by Mariangela Figini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariangela Figini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariangela Figini. The network helps show where Mariangela Figini may publish in the future.

Co-authorship network of co-authors of Mariangela Figini

This figure shows the co-authorship network connecting the top 25 collaborators of Mariangela Figini. A scholar is included among the top collaborators of Mariangela Figini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariangela Figini. Mariangela Figini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review 2021 ·Biomedicines ·(unknown), Elena Luison, Alessandro Desideri, Federico Iacovelli, Chiara Camisaschi, Ettore Seregni, Silvana Canevari, Mariangela Figini	4
2	SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region 2021 ·Cancers ·Chiara Maura Ciniselli, (unknown), Loris De Cecco, (unknown), (unknown), Elena Luison, Cecilia Melani, Maria Grazia Daidone, Giovanni Apolone, Paolo Verderio, Mariangela Figini	0
3	IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype 2020 ·Cancers ·Mano Nakamura, (unknown), Gabriel Osborn, Roman Laddach, Jitesh Chauhan, Chara Stavraka, Sara Lombardi, (unknown), Atousa Khiabany, (unknown), Mariangela Figini, A. Winship, Sharmistha Ghosh, Ana Montes, James Spicer, Heather J. Bax, Debra H. Josephs, Katie E. Lacy, Sophia Tsoka, Sophia N. Karagiannis	16
4	Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody 2020 ·Cells ·(unknown), Mariangela Figini, (unknown), (unknown), Marzia Pennati, Alessandro M. Gianni, Cinzia De Marco, Maria Grazia Daidone, Christian Argueta, Yosef Landesman, Nadia Zaffaroni, (unknown)	12
5	Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 2020 ·Scientific Reports ·Debora Carpanese, Guillermina Ferro‐Flores, Blanca Ocampo‐García, Clara Santos‐Cuevas, (unknown), Mariangela Figini, Giulio Fracasso, Laura De Nardo, Cristina Bolzati, Antonio Rosato, Laura Meléndez‐Alafort	14
6	Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle 2019 ·Journal of Experimental & Clinical Cancer Research ·(unknown), (unknown), Elena Luison, Ettore Seregni, Alice Lorenzoni, (unknown), R. Valdagni, A. Bogni, Claudio Chiesa, Marta Mira-Aladrén, Silvana Canevari, Alessandra Alessi, Mariangela Figini	15
7	Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells 2018 ·Frontiers in Immunology ·Isabel Corrêa, Kristina M. Ilieva, Silvia Crescioli, Sara Lombardi, Mariangela Figini, Anthony Cheung, James Spicer, Andrew Tutt, Frank O. Nestlé, Panagiotis Karagiannis, Katie E. Lacy, Sophia N. Karagiannis	13
8	Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level 2016 ·Journal of Hematology & Oncology ·(unknown), Qunrui Ye, Mathilde Poussin, Jessica Chacon, Mariangela Figini, Daniel J. Powell	94
9	In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB) 2011 ·Cancer Research ·(unknown), Qunrui Ye, Carmine Carpenito, Mathilde Poussin, Liping Wang, Chunyan Ji, Mariangela Figini, Carl H. June, George Coukos, Daniel J. Powell	237
10	Antibody Engineering as Opportunity for Selection and Optimization of Anti- HIV Therapeutic Agents 2010 ·(unknown), Silvana Canevari, Mariangela Figini	1
11	177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts 2009 ·Nuclear Medicine and Biology ·(unknown), Angela Coliva, Elena Luison, Ettore Seregni, Emilio Bombardieri, A. Giussani, Mariangela Figini, Silvana Canevari	23
12	Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 2009 ·Journal of Translational Medicine ·Samuele E. Burastero, Mariangela Figini, (unknown), Paolo Lusso, Luca Mollica, Lucia Lopalco	5
13	Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 2008 ·Clinical Cancer Research ·Giancarlo Castellano, Grazia Malaponte, María Clorinda Mazzarino, Mariangela Figini, Francesco P. Marchese, Pietro Gangemi, Salvatore Travali, Franca Stivala, Silvana Canevari, Massimo Libra	98
14	Redirected Activity of Human Antitumor Chimeric Immune Receptors is Governed by Antigen and Receptor Expression Levels and Affinity of Interaction 2007 ·Journal of Immunotherapy ·Fabio Turatti, Mariangela Figini, Emanuela Balladore, Paola Alberti, Patrizia Casalini, James D. Marks, Silvana Canevari, Delia Mezzanzanica	63
15	The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer 2006 ·Clinical Cancer Research ·Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, Yasuhiro Ikeda, Ann L. Oberg, Mariangela Figini, Silvana Canevari, Lynn C. Hartmann, Kah-Whye Peng	73
16	Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor 2004 ·The Journal of Gene Medicine ·Fabio Turatti, Mariangela Figini, Paola Alberti, Ralph A. Willemsen, Silvana Canevari, Delia Mezzanzanica	20
17	A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing 2004 ·Oncogene ·Alessia Gaggero, (unknown), Delia Mezzanzanica, Tiziana Piazza, Anna Rubartelli, Mariangela Figini, Silvana Canevari, Silvano Ferrini	27
18	Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2 2001 ·Cancer Immunology Immunotherapy ·Fabio Turatti, Delia Mezzanzanica, Elena Nardini, Elena Luison, Lorenzo Maffioli, Emilio Bombardieri, Claudia de Lalla, Silvana Canevari, Mariangela Figini	8
19	Single-step purification of immunotoxins containing a high ionic charge ribosome inactivating protein clavin by carboxymethyl high-performance membrane chromatography 1999 ·Journal of Chromatography A ·Franco Dosio, Silvia Arpicco, S. Canevari, Mariangela Figini, Daniela Gastaldi	4
20	Glycolipids carrying Le^y are preferentially expressed on small‐cell lung cancer cells as detected by the monoclonal antibody MLuC1 1992 ·International Journal of Cancer ·Flavio Leoni, Maria I. Colnaghi, Silvana Canevari, Sylvie Ménard, (unknown), (unknown), Mariangela Figini, Silvia Miotti, John L. Magnani	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact